Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rio

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|February 6, 2013
Cellular immune responses in multiple sclerosis patients treated with interferon-betaM F Bustamante, J Rio, Z Castro, et al.
Recent Patents on Biotechnology|November 14, 2015
Bioprospecting of Brevibacillus brevis isolated from soilAntony V Samrot, Rejin J J Prasad, Antony J Rio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 1998
Lack of association between hepatitis G virus and multiple sclerosisS Sauleda, J Rio, X Montalban, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1996
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosisC Nos, M Comabella, M Tintoré, et al.
AJNR. American Journal of Neuroradiology|December 10, 1999
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR imagesA Rovira, J Alonso, G Cucurella, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2009
Plasma chitotriosidase activity in multiple sclerosisM Comabella, C Domínguez, J Rio, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2011
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosisJ E Martínez-Rodríguez, M López-Botet, E Munteis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohortR Pelayo, M Tintoré, A Rovira, et al.
Revista De Neurologia|January 29, 2019
[Progressive multifocal leukoencephalopathy and non-specific immune dysfunction]D Campos-Fernandez, M Olive-Gadea, A Ballve-Martin, et al.
Revista De Enfermeria (Barcelona, Spain)|June 21, 2008
[Terminal illness, death... in the words of professionals. A qualitative study based on in-depth interviews with health professionals]García M P Caro, Schmidt J Rio-Valle, Cruz F Quintana, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|February 6, 2013
Cellular immune responses in multiple sclerosis patients treated with interferon-betaM F Bustamante, J Rio, Z Castro, et al.
Recent Patents on Biotechnology|November 14, 2015
Bioprospecting of Brevibacillus brevis isolated from soilAntony V Samrot, Rejin J J Prasad, Antony J Rio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 1998
Lack of association between hepatitis G virus and multiple sclerosisS Sauleda, J Rio, X Montalban, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1996
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosisC Nos, M Comabella, M Tintoré, et al.
AJNR. American Journal of Neuroradiology|December 10, 1999
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR imagesA Rovira, J Alonso, G Cucurella, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2009
Plasma chitotriosidase activity in multiple sclerosisM Comabella, C Domínguez, J Rio, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2011
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosisJ E Martínez-Rodríguez, M López-Botet, E Munteis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohortR Pelayo, M Tintoré, A Rovira, et al.
Revista De Neurologia|January 29, 2019
[Progressive multifocal leukoencephalopathy and non-specific immune dysfunction]D Campos-Fernandez, M Olive-Gadea, A Ballve-Martin, et al.
Revista De Enfermeria (Barcelona, Spain)|June 21, 2008
[Terminal illness, death... in the words of professionals. A qualitative study based on in-depth interviews with health professionals]García M P Caro, Schmidt J Rio-Valle, Cruz F Quintana, et al.
Pageof 4